Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

CAR T-cell in elderly patients suffering from non-Hodgkin lymphoma or multiple myeloma

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Guillaume Dachy

Non-relapse mortality post CAR-T cell therapy

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Charlotte Graham

HSCT in patients with GLIS2+ AML study

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Second allogeneic HSCT for relapsed pediatric ALL: a collaborative study on behalf of the Brazilian PDWP (SBTMO) and the European EBMT PDWP (J. Silva, C. Bonfim)

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Julia Silva, Carmen Bonfim

Outcomes of children with AML relapse within 6 months post HSCT (C. Horgan/R. Wynn)

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Claire Horgan / Rob Wynn

Allogeneic vs autologous HSCT in B-cell NHL (D. Przystupski)

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

IL2Rα and IL2Rβ Deficiencies - Clinical Phenotype and HSCT Outcome, a joint ESID/EBMT IEWP study

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type de traitement

Investigateur principal

Christo Tsilifis, Ina Schim van der Loeff, Lisa Ott de Bruin, Florian Goethe, Ommo Mauss, Mehtap Sirin, Mary Slatter, Sophie Hambleton

Indications and outcomes of HSCT for MSMD due to defects of IL12- and IL23-signalling

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type de traitement

Investigateur principal

Tanja Vallée and Michael Albert

Clinical features, HSCT indications and outcome of HSCT in Ras-Associated Autoimmune Leukoproliferative Disorder (RALD), a joint ESID/EBMT IEWP study

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type de traitement

Allogeneic - Related

Allogeneic - Unrelated

Allogeneic - Haploidentical

Investigateur principal

Alexandra Laberko, Srividhya Senthil, Andrew Gennery

Clinical presentations, treatments, and outcomes in an international cohort with ZNFX1 deficiency

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type de traitement

Allogeneic - Related

Allogeneic - Unrelated

Allogeneic - Haploidentical

Investigateur principal

Outcomes of Haematopoietic Stem Cell Transplant for MHC Class II deficiency

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type de traitement

Allogeneic - Related

Allogeneic - Unrelated

Allogeneic - Haploidentical

Investigateur principal

Kanchan Rao and Isabelle Meyts

Allogeneic haematopoietic stem cell transplantation in infantile osteopetrosis

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type de traitement

Allogeneic - Related

Allogeneic - Unrelated

Allogeneic - Haploidentical

Investigateur principal